Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the <scp>TOPICOP</scp><sup>®</sup> scale: prevalence, risk factors and the impact of therapeutic patient education

Gonzales, Fanny; Ramdane, Nassima; Delebarre-Sauvage, C.; Modiano, P.; Duhamel, Alain; Lasek, A.

doi:10.1111/jdv.13961

Cited by 23 publications

(25 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although previous studies reported the effect of patient education on AD in terms of eczema severity and quality of life, they did not examine changes in steroid anxiety. Recently, in their prospective study using TOPICOP, Gonzales et al reported that therapeutic patient education (TPE) significantly decreased TCS phobia among AD patients and demonstrated that the scores for the belief and worry categories and the total score were significantly lower after TPE . Our findings generally agreed with their results except for the worry category score, which did not decrease significantly in our study possibly as a result of a difference in the timing of TOPICOP administration.…”

Section: Discussionsupporting

confidence: 91%

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Saito‐Abe

Futamura

Yamamoto‐Hanada

et al. 2019

Pediatric Dermatology

View full text Add to dashboard Cite

All the authors have approved the manuscript and agree with submission to Pediatric Dermatology.This study was carried out with the approval of the hospital ethics committee of the National Center for Child Health and Development (Reception number: 761). AbstractBackground/Objectives: The TOPICOP scale is an easy-to-use scale for assessing topical corticosteroid (TCS) phobia in atopic dermatitis (AD) patients and their caretakers. TCS phobia is a common problem among AD patients and their caretakers.The aim of this study was to examine the relationship between TCS phobia in caretakers of children with AD and the characteristics of patients using the TOPICOP scale. Methods: Caretakers of AD patients who visited the allergy clinic at the National Center for Child Health and Development in Tokyo between February 2014 and May 2014 were recruited. Caretakers of patients in follow-up had already attended an education session on treatment at the institution. All participants completed an anonymous questionnaire on the characteristics of the respondents and patients using the Patient-Oriented Eczema Measure (POEM) and the Japanese version of TOPICOP.Results: In total, 243 participants (88.9% female) completed the survey. The average TOPICOP score was 40.3 and the median POEM score was 4. The TOPICOP score was significantly higher for patients younger than 12 months old with moderate to very severe AD (POEM ≥ 8) whose caretaker had not attended an educational session (P < 0.01, respectively). There was no significant difference in the family history of AD, age, or gender of the respondents. In multivariable analysis, preattendance at an education session was the only significant factor accounting for a higher TOPICOP score (P < 0.001). Conclusions:Regardless of their background, caretakers of AD patients can be affected from TCS phobia. Attending an educational session might ease their anxiety. K E Y W O R D S atopic dermatitis, questionnaire, steroid phobia, topical corticosteroid, TOPICOP 312 | Pediatric Dermatology SAITO-ABE ET Al. Patients Age, median (range) 238 4 (range: 0-17) POEM, median (range) 243 4 (2-9) Very severe (25-28), n (%) 2 (0.8) Severe (17-24), n (%) 17 (7.0) Moderate (8-16), n (%) 60 (24.7) Mild (3-7), n (%) 72 (29.6) Clear or almost clear (0-2), n (%) 92 (37.9) AD class attendance: Preattendance, n (%) 237 95(40.1) Family history of AD, n (%) 243 143 (58.8) Mother history, n (%) 243 74 (30.5) Father history, n (%) 243 77 (31.7) Sibling history, n (%) 243 50 (20.6) a Number of respondents and patients without missing value.

show abstract

Section: Discussionsupporting

confidence: 91%

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Saito‐Abe

Futamura

Yamamoto‐Hanada

et al. 2019

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…Studies (12,13) have found that parents of girls had a higher TOPICOP score, while another study (5) found that mothers had higher TOPICOP scores. A study of adults and children with various skin conditions also found that female participants had greater steroid phobia.…”

Section: Discussionmentioning

confidence: 99%

Corticosteroid phobia: a questionnaire study using TOPICOP score

Choi¹,

Chandran²,

Tan³

2020

smedj

View full text Add to dashboard Cite

“…12 Several studies indicate that this questionnaire is applicable for patients and parents in different settings and can be used internationally. 8,13,14 The current study assesses and compares the worries and beliefs concerning topical corticosteroids of parents of children with atopic dermatitis and involved health care professionals, and between different professionals. Finally, we sought factors associated with corticophobia in professionals.…”

Section: Introductionmentioning

confidence: 99%

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Bos

Antonescu

Osinga

et al. 2018

Pediatric Dermatology

View full text Add to dashboard Cite

Background Adherence to topical corticosteroids is low among atopic dermatitis patients and their parents. This can lead to treatment failure and decreased quality of life. Objective To assess and compare the worries and beliefs concerning topical corticosteroids among parents of children with atopic dermatitis, involved health care professionals, and between different professionals. Also, we identify factors associated with corticosteroid phobia (corticophobia) in professionals. Methods Parents and health care professionals were invited to complete a questionnaire about corticophobia (Topicop). Higher questionnaire scores, expressed as a percentage, indicate more severe corticophobia. Professionals were asked to answer the questions as though they were using topical corticosteroids on their own child. Results The scores for 29 parents and 31 public health care nurses were equal: 44%. The score for 51 general practitioners was 39%. The score for 33 public health care physicians and of 47 pediatricians was 31%. The differences between parents and these professionals were statistically significantly different (P = 0.001). Type of profession and having a child with atopic dermatitis were significantly associated factors for the score. Conclusion Corticophobia is present among parents of children with atopic dermatitis and among health care professionals involved in caring for children with atopic dermatitis. Health care nurses express the same level of corticophobia as parents. The presence of corticophobia among health care professionals may affect parental perspectives and topical corticosteroids adherence negatively.

show abstract

Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP^® scale: prevalence, risk factors and the impact of therapeutic patient education

Cited by 23 publications

References 10 publications

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Corticosteroid phobia: a questionnaire study using TOPICOP score

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Contact Info

Product

Resources

About

Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education

Cited by 23 publications

References 10 publications

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Topical corticosteroid phobia among caretakers of children with atopic dermatitis: A cross‐sectional study using TOPICOP in Japan

Corticosteroid phobia: a questionnaire study using TOPICOP score

Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers

Contact Info

Product

Resources

About

Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP^® scale: prevalence, risk factors and the impact of therapeutic patient education